Filtros de búsqueda

Lista de obras de

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids

artículo científico publicado en 2012

A structured review evaluating content validity of the Asthma Control Test, and its consistency with U.S. guidelines and patient expectations for asthma control

artículo científico publicado en 2020

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

artículo científico publicado en 2014

Corrigendum to “Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial” [Res Med 108 (2014) 41–49]

article

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

article

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

article

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial

artículo científico publicado en 2013

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

artículo científico publicado en 2014

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

artículo científico publicado en 2011

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

artículo científico

Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial

artículo científico publicado en 2014

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

artículo científico publicado en 2011

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone ⬇️

artículo científico publicado en 2013

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

artículo científico publicado en 2013

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids

artículo científico publicado en 2012

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda